We are live on
!
Find out more
CCM
Canal Capital Management Portfolio holdings
AUM
$739M
1-Year Est. Return
19.12%
This Fund
S&P 500
This Quarter
Est. Return
-14.01%
1 Year Est. Return
+19.12%
3 Year Est. Return
+58.38%
5 Year Est. Return
+75.24%
10 Year Est. Return
+260.82%
AUM
$148M
AUM Growth
-$28.4M
(-16%)
Cap. Flow
-$3.09M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
31.29%
Holding
125
New
10
Increased
61
Reduced
38
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$1.31M |
| 3 |
First Trust Morningstar Dividend Leaders Index Fund
FDL
|
+$1.18M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.03M |
| 5 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$858K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$3.21M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.96M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$1.93M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.23M |
| 5 |
Biogen
BIIB
|
+$854K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.36% |
| 2 | Financials | 11.83% |
| 3 | Technology | 6.68% |
| 4 | Consumer Discretionary | 6.44% |
| 5 | Healthcare | 5.2% |
Similar funds
CNB
QI
JJBC
ROC
AFG
GWS
TWP
HCP
Canal Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Canal Capital Management held 125 positions worth $148M, down 16% from $176M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Canal Capital Management's Q4 2018 filing shows 10 new, 61 increased, 38 reduced and 14 closed positions. Its largest new stake was iShares Biotechnology ETF: 12,296 shares worth $1.19M. The largest sale was State Street DoubleLine Total Return Tactical ETF, an estimated $3.21M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 13% a quarter earlier, followed by Financials and Technology.
- Canal Capital Management's largest Q4 2018 buy was iShares Biotechnology ETF: 12,296 shares worth $1.19M.
- Canal Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.42M increase.
- Canal Capital Management's biggest Q4 2018 reduction was State Street DoubleLine Total Return Tactical ETF, cutting an estimated $3.21M.
- Canal Capital Management fully exited Vanguard FTSE Europe ETF in Q4 2018, selling an estimated $1.93M.
- Canal Capital Management's ten largest holdings make up 31% of its $148M portfolio in Q4 2018.
- Canal Capital Management opened 10 new positions and closed 14 in Q4 2018.
- Canal Capital Management's portfolio value fell 16% quarter-over-quarter to $148M.
Based on Canal Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.